These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20600509)

  • 1. A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus.
    Hu WG; Phelps AL; Jager S; Chau D; Hu CC; O'Brien LM; Perkins SD; Gates AJ; Phillpotts RJ; Nagata LP
    Vaccine; 2010 Aug; 28(34):5558-64. PubMed ID: 20600509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III.
    Phillpotts RJ
    Virus Res; 2006 Sep; 120(1-2):107-12. PubMed ID: 16621103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
    Elvin SJ; Bennett AM; Phillpotts RJ
    J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus.
    Goodchild SA; O'Brien LM; Steven J; Muller MR; Lanning OJ; Logue CH; D'Elia RV; Phillpotts RJ; Perkins SD
    Antiviral Res; 2011 Apr; 90(1):1-8. PubMed ID: 21310183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus.
    Hunt AR; Frederickson S; Hinkel C; Bowdish KS; Roehrig JT
    J Gen Virol; 2006 Sep; 87(Pt 9):2467-2476. PubMed ID: 16894184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge.
    O'Brien LM; Goodchild SA; Phillpotts RJ; Perkins SD
    Virology; 2012 May; 426(2):100-5. PubMed ID: 22341308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
    Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
    Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus.
    Phillpotts RJ; Jones LD; Howard SC
    Vaccine; 2002 Feb; 20(11-12):1497-504. PubMed ID: 11858855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virus.
    Hu WG; Chau D; Wu J; Jager S; Nagata LP
    Vaccine; 2007 Apr; 25(16):3210-4. PubMed ID: 17289226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.
    Parker MD; Buckley MJ; Melanson VR; Glass PJ; Norwood D; Hart MK
    J Virol; 2010 Dec; 84(24):12683-90. PubMed ID: 20926570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains.
    O'Brien LM; Underwood-Fowler CD; Goodchild SA; Phelps AL; Phillpotts RJ
    Virol J; 2009 Nov; 6():206. PubMed ID: 19925641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
    Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.